{"eventGroups":[{"description":"Patients receive palifosfamide IV over 30 minutes on days 1-3. Treatment repeats every 21 days for up to 6 courses in the absence of disease progression or unacceptable toxicity.","id":"EG000","otherNumAffected":4,"otherNumAtRisk":5,"seriousNumAffected":2,"seriousNumAtRisk":5,"title":"Treatment (Palifosfamide)"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Abdominal pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":5}],"term":"Constipation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Diarrhea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":5}],"term":"Nausea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Edema limbs"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":5}],"term":"Fatigue"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Non-cardiac chest pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":5}],"term":"Anorexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":5}],"term":"Back pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Peripheral sensory neuropathy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Insomnia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Acute kidney injury"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":5}],"term":"Dyspnea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Hypoxia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Pleural effusion"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Pruritus"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Thromboembolic event"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Small intestinal obstruction"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (9.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":5}],"term":"Hypoglycemia"}],"timeFrame":"Up to 2 years"}